Arsenic induces the expressions of angiogenesis-related factors through PI3K and MAPK pathways in SV-HUC-1 human uroepithelial cells

Toxicology Letters

Volumn 222, Issue 3, 2013, Pages 303-311

  Wang, Fei ^a   Liu, Shengnan ^a   Xi, Shuhua ^a   Yan, Ling ^a   Wang, Huihui ^a   Song, Yingli ^a   Sun, Guifan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Arsenite; COX 2; HIF 1 ; MAPK; PI3K AKT; VEGF

Indexed keywords

ARSENIC; CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ARSENITE; COX-2; HIF-1Α; MAPK; PI3K/AKT; VEGF;

ARSENIC POISONING; ARSENITES; BLOTTING, WESTERN; CELL LINE; CYCLOOXYGENASE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UROTHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884185262     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.08.008     Document Type: Article

References (57)

1. Aballay L.R., Díaz Mdel P., Francisca F.M., Muñoz S.E. Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina. Int. J. Environ. Health Res. 2012, 22:220-231.
2. Bussink J., van der Kogel A.J., Kaanders J.H. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol. 2008, 9:288-296.
3. Chai C.Y., Huang Y.C., Hung W.C., Kang W.Y., Chen W.T. Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells. Mutagenesis 2007, 22:403-408.
4. Chen C.J., Kuo T.L., Wu M.M. Arsenic and cancers (letter). Lancet 1988, 1:414-415.
5. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in Northeastern Taiwan. Am. J. Epidemiol. 2001, 153:411-418.
6. Cohen S.M., Tatematsu M., Shinohara Y., Nakanishi K., Ito N. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. J. Natl. Cancer Inst. 1980, 65:145-148.
7. Cui Y., Han Z., Hu Y., Song G., Hao C., Xia H., Ma X. Micro RNA-181b and micro RNA-9 mediate arsenic-induced angiogenesis via NRP1. J. Cell. Physiol. 2012, 227:772-783.
8. Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 2008, 8:51-56.
9. Eblin K.E., Bredfeldt T.G., Buffington S., Gandolfi A.J. Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis. Toxicol. Sci. 2007, 95:321-330.
10. Eblin K.E., Jensena T.J., Wnek S.M., Buffington S.E., Futschera B.W., Gandolfi A.J. Reactive oxygen species regulate properties of transformation in UROtsa cells exposed to monomethylarsonous acid by modulating MAPK signaling. Toxicology 2009, 255:107-114.
11. El-Sheikh S.S., Madaan S., Alhasso A., Abel P., Stamp G., Lalani E.N. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. BJU Int. 2001, 88:921-927.
12. Feng L., Sun W., Xia Y., Tang W.W., Chanmugam P., Soyoola E., Wilson C.B., Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 1993, 307:361-368.
13. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
14. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16:4604-4613.
15. Galanis A., Pappa A., Giannakakis A., Lanitis E., Dangaj D., Sandaltzopoulos R. Reactive oxygen species and HIF-1 signaling in cancer. Cancer Lett. 2008, 266:12-20.
16. Gao J.C., Tian J., Lv Y., Shi F., Kong F., Shi H., Zhao L. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 2008, 100:389-395.
17. Gentry P.R., McDonald T.B., Sullivan D.E., Shipp A.M., Yager J.W., Clewell H.J. Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ. Mol. Mutagen. 2010, 51:1-14.
18. Haddad J.J. Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur. Cytokine Netw. 2002, 13:250-260.
19. Hammam O.A., Aziz A.A., Roshdy M.S., Abdel Hadi A.M. Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer. Medscape J. Med. 2008, 10:60.
20. Huang C., Ke Q., Costa M., Shi X. Molecular mechanisms of arsenic carcinogenesis. Mol. Cell. Biochem. 2004, 255:57-66.
21. IARC.Working Group on the Evaluation of Carcinogenic Risks to Humans Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 84:1-447.
22. Iniguez M.A., Rodríguez A., Volpert O.V., Fresno M., Redondo J.M. Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol. Med. 2003, 9:73-78.
23. Jones A., Fujiyama C., Blanche C., Moore J.W., Fuggle S., Cranston D., Bicknell R., Harris A.L. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clin. Cancer Res. 2001, 7:1263-1272.
24. Jung S.N., Yang W.K., Kim J., Kim H.S., Kim E.J., Yun H., Park H., Kim S.S., Choe W., Kang I., Ha J. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 2008, 29:713-721.
25. Kaidi A., Qualtrough D., Williams A.C., Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 2006, 66:6683-6691.
26. Kamat C.D., Green D.E., Curilla S., Warnke L., Hamilton J.W., Sturup S., Clark C., Ihnat M.A. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol. Sci. 2005, 86:248-257.
27. Kaur B., Khwaja F.W., Severson E.A., Matheny S.L., Brat D.J., Van Meir E.G. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neurol. Oncol. 2005, 7:134-153.
28. Kim H.G., Hwang Y.P., Jeong H.G. Metallothionein-III induces HIF-1alpha-mediated VEGF expression in brain endothelial cells. Biochem. Biophys. Res. Commun. 2008, 369:666-671.
29. Krysan K., Reckamp K.L., Dalwadi H., Sharma S., Rozengurt E., Dohadwala M., Dubinett S.M. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res. 2005, 65:6275-6281.
30. Letasiova S., Medveova A., Sovcíkova A., Dusinska M., Volkovova K., Mosoiu C., Bartonová A. Bladder cancer, a review of the environmental risk factors. Environ. Health. 2012, 10.1186/1476-069X-11-S1-S11.
31. Ling M., Li Y., Xu Y., Pang Y., Shen L., Jiang R., Zhao Y., Yang X., Zhang J., Zhou J., Wang X., Liu Q. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-kappa B in arsenite-induced cell transformation. Free Radic. Biol. Med. 2012, 52:1508-1518.
32. Liu C.H., Chang S.H., Narko K., Trifan O.C., Wu M.T., Smith E., Haudenschild C., Lane T.F., Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem. 2001, 276:18563-18569.
33. Liu L.Z., Jiang Y., Carpenter R.L., Jing Y., Peiper S.C., Jiang B.H. Role and mechanism of arsenic in regulating angiogenesis. PLos One 2011, 10.1371/journal.pone.0020858.
34. Majhi C.R., Khan S., Leo M.D., Manimaran A., Sankar P., Sarkar S.N. Effects of acetaminophen on reactive oxygen species and nitric oxide redox signaling in kidney of arsenic-exposed rats. Food Chem. Toxicol. 2011, 49:974-982.
35. Mizukami Y., Kohgo Y., Chung D.C. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin. Cancer Res. 2007, 13:5670-5674.
36. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7:359-371.
37. Pore N., Liu S., Shu H.K., Li B., Haas-Kogan D., Stokoe D., Milanini-Mongiat J., Pages G., O'Rourke D.M., Bernhard E., Maity A. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell 2004, 15:4841-4853.
38. Ristimaki A., Niemi nen O., Saukkone N.K., Hota-kainen K., Nordling S., Haglund C. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am. J. Pathol. 2001, 158:849-853.
39. Rodriguez C., Mayo J.C., Sainz R.M., Antolín I., Herrera F., Martín V., Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 2004, 36:1-9.
40. Semenza G.L. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov. Today 2007, 12:853-859.
41. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. 2003, 3:721-732.
42. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., Chen Y., Shi X., Liu K.J. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 2004, 17:871-878.
43. Shirahama T., Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin. Cancer Res. 2001, 7:558-561.
44. Steinmaus C.M., Ferreccio C., Romo J.A., Yuan Y., Cortes S., Marshall G., Moore L.E., Balmes J.R., Liaw J., Golden T., Smith A.H. Drinking water arsenic in northern Chile: high cancer risks 40 years after exposure cessation. Cancer Epidemiol. Biomarkers Prev. 2013, 22:623-630.
45. Taketani T., Tamura H., Takasaki A., Lee L., Kizuka F., Tamura I., Taniguchi K., Maekawa R., Asada H., Shimamura K., Reiter R.J., Sugino N. Protective role of melatonin in progesterone production by human luteal cells. J. Pineal Res. 2011, 51:207-213.
46. Tatematsu M., Cohen S.M., Fukushima S., Shirai T., Shinohara Y., Ito N. Neovascularization in benign and malignant urinary bladder epithelial proliferative lesions of the rat observed in situ by scanning electron microscopy and autoradiography. Cancer Res. 1978, 38:1792-1800.
47. Turner K.J., Moore J.W., Jones A., Taylor C.F., Cuthbert-Heavens D., Han C., Leek R.D., Gatter K.C., Maxwell P.H., Ratcliffe P.J., Cranston D., Harris A.L. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res. 2002, 62:2957-2961.
48. Wang D., Buchanan F.G., Wang H., Dey S.K., DuBois R.N. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res. 2005, 65:1822-1829.
49. 2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
50. Wang G.L., Semenza G.L. Purification, characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995, 270:1230-1237.
51. Wang H.H., Xi S.H., Xu Y.Y., Wang F., Zheng Y., Li B., Li X., Zheng Q., Sun G. Sodium arsenite induces cyclooxygenase-2 expression in human uroepithelial cells through MAPK pathway activation and reactive oxygen species induction. Toxicol. In Vitro 2013, 10.1016/j.tiv.2013.01.012.
52. Wang J., Zhang W., Sun D., Song L., Li Y., Xu C. Analysis of neuroglobin mRNA expression in rat brain due to arsenite-induced oxidative stress. Environ. Toxicol. 2012, 27:503-509.
53. Wang T.C., Jan K.Y., Wang A.S., Gurr J.R. Trivalent arsenicals induce lipid peroxidation protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. 2007, 615:75-86.
54. Williams C.S., DuBois R.N. Prostaglandin endoperoxide synthase: why two isoforms?. Am. J. Physiol. 1996, 270:G393-G400.
55. Yoshie M., Miyajima E., Kyo S., Tamura K. Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible factor-1α levels in human endometrial and endothelial cells. Endocrinology 2009, 150:2413-2418.
56. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin. Hemorheol. Microcirc. 2006, 34:109-115.
57. Zagorska A. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim. Pol. 2004, 51:563-585.